Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 5Withdrawn 1Unknown 1Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Breast Neoplasms 24Colorectal Neoplasms 19Rectal Neoplasms 11Stomach Neoplasms 9Colonic Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Carcinoma, Hepatocellular 7Neoplasm Metastasis 6Squamous Cell Carcinoma of Head and Neck 5Neoplasms 5Liver Neoplasms 5Esophageal Neoplasms 5Uterine Cervical Neoplasms 4Urinary Bladder Neoplasms 4Osteosarcoma 4Cholangiocarcinoma 4Peritoneal Neoplasms 3Ovarian Neoplasms 3Neuroblastoma 3Multiple Myeloma 3Lung Neoplasms 3Locally Advanced Rectal Cancer 3Kidney Neoplasms 3Inflammatory Breast Neoplasms 3Turcot syndrome 2Sarcoma 2Pancreatic Neoplasms 2Nasopharyngeal Carcinoma 2Head and Neck Neoplasms 2Glioblastoma 2

Interventions

Radiotherapy 19Temozolomide 11Cisplatin 9Vincristine 8Chemotherapy, Adjuvant 8Carboplatin 8Etoposide 6Lomustine 5Methotrexate 4Thiotepa 3Peripheral Blood Stem Cell Transplantation 3Magnetic Resonance Spectroscopy 3Ifosfamide 3Filgrastim 3Cyclophosphamide 3Carmustine 3pegfilgrastim 2Tamoxifen 2Surgical Procedures, Operative 2Psychiatric Rehabilitation 2Pemetrexed 2Mental Status and Dementia Tests 2Hyperbaric Oxygenation 2Ethanol 2Erlotinib Hydrochloride 2Dexamethasone 2Amplified Fragment Length Polymorphism Analysis 2nedaplatin 1motexafin gadolinium 1lonafarnib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Central Nervous System Neoplasms × Neoadjuvant Therapy × Clear all
NCT00003788 2013-11-06

Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas

National Cancer Institute (NCI)

Phase 3 Unknown
270 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡